Mutual Fund Ownership
Ownership as on: Wed, 22 May, 2024

HDFC Retirement Savings Fund - Hybrid Debt Plan - Regular Plan

NA
Solutions Oriented
Amount Invested (Cr.)13.34
% of AUM8.48%

SBI Equity Minimum Variance Fund Regular Growth

NA
Equity
Amount Invested (Cr.)15.38
% of AUM8.10%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)66.79
% of AUM7.47%

Mirae Asset Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)161.53
% of AUM7.22%

FAQs about Dr Reddys Laboratories share price

Dr Reddys Laboratories is trading at 5872.65 as on Wed May 22 2024 10:17:00. This is 1.59% upper as compared to its previous closing price of 5780.70.

The market capitalization of Dr Reddys Laboratories is 97796.34 Cr as on Wed May 22 2024 10:17:00.

The average broker rating on Dr Reddys Laboratories is Hold. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 7 analysts have given a buy rating
  • 9 analysts have given a hold rating
  • 8 analysts have given a sell rating
  • 4 analysts have given a strong sell rating

The 52 wk high for Dr Reddys Laboratories is 6505.50 whereas the 52 wk low is 4385.70

Dr Reddys Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 18.37
  • Sector P/E: 31.64
  • Dividend Yield: 0.69%
  • D/E ratio: 0.07

Dr Reddys Laboratories reported a net profit of 5577.90 Cr in 2024.

Recommended For You
Trending Stocks
2,366.80+56.55(2.45%)
2,920.75+49.45(1.72%)
1,454.65+20.45(1.43%)
819.30-11.25 (-1.35%)
1,127.70-9.90 (-0.87%)
HomeMarketsPremiumFor youGet App